$136-160k
+ Annual performance-based bonus + Long-term incentive units (equity)
More information about location
Platform personalising cancer testing
Be an early applicant
Platform personalising cancer testing
201-500 employees
Be an early applicant
$136-160k
+ Annual performance-based bonus + Long-term incentive units (equity)
More information about location
201-500 employees
To transform the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response.